Domů › Rakovina endometria › Florida › Orlando
Klinické studie Rakovina endometria v Orlando, FL
17 studií pro Rakovina endometria hledá účastníky v lokalitách v Orlando a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Probíhá náborFáze 1/2
- Advent Health, Orlando
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Probíhá náborFáze 1
- AdventHealth Cancer Institute, Orlando
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Probíhá náborFáze 2
- AdventHealth Medical Group Oncology Research at Celebration, Kissimmee · Vzdálenost 16 mi
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Probíhá náborObservační studie
- Orlando Health, Orlando
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Probíhá náborFáze 1
- Sara Cannon Research Institute Lake Nona, Orlando
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Probíhá náborFáze 3
- AdventHealth Orlando-AdventHealth Medical Group Gynecological Oncology ( Site 6002), Orlando
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Probíhá náborFáze 1/2
- Florida Cancer Specialists - Lake Nona, Orlando
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Probíhá náborFáze 1
- Sarah Cannon Research Institute - Lake Nona Florida, Orlando
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
Probíhá náborFáze 1
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Probíhá náborFáze 3
- Research Site, Orlando
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
Probíhá náborFáze 1/2
- Florida Cancer Specialists, Orlando
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Probíhá náborFáze 1/2
- AdventHealth Celebration, Celebration · Vzdálenost 17 mi
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
Probíhá náborObservační studie
- ADVENTHEALTH (Data collection only), Orlando
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Probíhá náborFáze 3
- Research Site, Orlando
A Study of LY4175408 in Participants With Advanced Cancer
Probíhá náborFáze 1
- Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute, Orlando
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Probíhá náborFáze 1
- Dren Investigational Site, Orlando
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
Probíhá náborFáze 2
- Orlando Health, Orlando
Studie Rakovina endometria v jiných městech
- Houston, TX68 studií
- New York City, NY52 studií
- Boston, MA50 studií
- Arlington, VA39 studií
- Nashville, TN38 studií
- Los Angeles, CA34 studií
- St. Louis, MO29 studií
- Philadelphia, PA28 studií
- San Antonio, TX27 studií
- Chicago, IL25 studií
- Columbus, OH25 studií
- Queens, NY25 studií
Další studie v Orlando
- Nemalobuněčný plicní karcinom44 studií
- Obesity31 studií
- Metastatický karcinom29 studií
- Nadváha27 studií
- Alzheimerova choroba25 studií
- Diabetes mellitus 2. typu24 studií
- Rakovina (všechny typy)24 studií
- Rakovina prsu23 studií
- Rakovina vaječníků22 studií
- Ulcerózní kolitida22 studií
- Rakovina plic21 studií
- Kolorektální karcinom19 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.